{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:16:14Z","timestamp":1793373374589,"version":"4.5.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["HIL-A03"],"award-info":[{"award-number":["HIL-A03"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Autoantibodies against proteins in the brain are increasingly considered as a potential cause of cognitive decline, not only in subacute autoimmune encephalopathies but also in slowly progressing impairment of memory in patients with classical neurodegenerative dementias. In this retrospective cohort study of 161 well-characterized patients with different forms of dementia and 34 controls, we determined the prevalence of immunoglobulin (Ig) G and IgA autoantibodies to brain proteins using unbiased immunofluorescence staining of unfixed murine brain sections. Autoantibodies were detected in 21.1% of dementia patients and in 2.9% of gender-matched controls, with higher frequencies in vascular dementia (42%), Alzheimer\u2019s disease (30%), dementia of unknown cause (25%), and subjective cognitive impairment (16.7%). Underlying antigens involved glial fibrillary acidic protein (GFAP), glycine receptor, and Rho GTPase activating protein 26 (ARHGAP26), but also a range of yet undetermined epitopes on neurons, myelinated fiber tracts, choroid plexus, glial cells, and blood vessels. Antibody-positive patients were younger than antibody-negative patients but did not differ in the extent of cognitive impairment, epidemiological and clinical factors, or comorbidities. Further research is needed to understand the potential contribution to disease progression and symptomatology, and to determine the antigenic targets of dementia-associated autoantibodies.<\/jats:p>","DOI":"10.3389\/fneur.2024.1412813","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:20:42Z","timestamp":1720585242000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Brain-targeting autoantibodies in patients with dementia"],"prefix":"10.3389","volume":"15","author":[{"given":"Finja","family":"Staabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Foverskov Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Buthut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"H\u00f6ltje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"St\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Teegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Pr\u00fcss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pr\u00fcss","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.molmed.2022.09.011","article-title":"Molecular disease mechanisms of human antineuronal monoclonal autoantibodies","volume":"29","author":"Duong","year":"2022","journal-title":"Trends Mol Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"711195","DOI":"10.3389\/fnagi.2021.711195","article-title":"Current nosology of neural autoantibody-associated dementia","volume":"13","author":"Hansen","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1111\/ene.12939","article-title":"Slowly progressive LGI1 encephalitis with isolated late-onset cognitive dysfunction: a treatable mimic of Alzheimer's disease","volume":"23","author":"Marquetand","year":"2016","journal-title":"Eur J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/archneur.64.10.1528","article-title":"Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome","volume":"64","author":"McKeon","year":"2007","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease","volume":"146","author":"Gruter","year":"2022","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/cells10040837","article-title":"Neurodegeneration induced by anti-IgLON5 antibodies studied in induced pluripotent stem cell-derived human neurons","volume":"10","author":"Ryding","year":"2021","journal-title":"Cells"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"100609","DOI":"10.1016\/j.bbih.2023.100609","article-title":"Immunoreactivity to astrocytes in different forms of dementia: high prevalence of autoantibodies to GFAP","volume":"29","author":"Barthel","year":"2023","journal-title":"Brain Behav Immun Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7555\/JBR.30.20150131","article-title":"Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications","volume":"30","author":"Wu","year":"2016","journal-title":"J Biomed Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3233\/JAD-171096","article-title":"Prevalence and determinants of agonistic autoantibodies against alpha1-adrenergic receptors in patients screened positive for dementia: results from the population-based DelpHi-study","volume":"64","author":"Thyrian","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neures.2014.06.002","article-title":"N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias","volume":"85","author":"Busse","year":"2014","journal-title":"Neurosci Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/acn3.120","article-title":"High prevalence of NMDA receptor IgA\/IgM antibodies in different dementia types","volume":"1","author":"Doss","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/cells10010077","article-title":"NMDA and AMPA receptor autoantibodies in brain disorders: from molecular mechanisms to clinical features","volume":"10","author":"Gardoni","year":"2021","journal-title":"Cells"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.schres.2014.10.007","article-title":"Anti-NMDA receptor encephalitis, autoimmunity, and psychosis","volume":"176","author":"Kayser","year":"2016","journal-title":"Schizophr Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/annonc\/mdz083","article-title":"Neuronal autoantibodies associated with cognitive impairment in melanoma patients","volume":"30","author":"Bartels","year":"2019","journal-title":"Ann Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2017.96","article-title":"A clinicopathological approach to the diagnosis of dementia","volume":"13","author":"Elahi","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/alz.12780","article-title":"Frontotemporal dementia associated with intrathecal antibodies against axon initial segments","volume":"19","author":"Endres","year":"2023","journal-title":"Alzheimers Dement"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.biopsych.2022.02.010","article-title":"Spectrum of novel anti\u2013central nervous system autoantibodies in the cerebrospinal fluid of 119 patients with schizophreniform and affective disorders","volume":"92","author":"Endres","year":"2022","journal-title":"Biol Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","article-title":"A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 Hamster model","volume":"183","author":"Kreye","year":"2020","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e13292","DOI":"10.1111\/nmo.13292","article-title":"High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders","volume":"30","author":"L\u00fctt","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1091\/mbc.E18-05-0274","article-title":"Compositional complexity of rods and rings","volume":"29","author":"Schiavon","year":"2018","journal-title":"Mol Biol Cell"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the international consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbi.2022.10.016","article-title":"Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: analysis of 49 autoantibodies in over 7000 subjects","volume":"108","author":"Daguano Gastaldi","year":"2023","journal-title":"Brain Behav Immun"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbi.2021.05.017","article-title":"Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder","volume":"96","author":"Giannoccaro","year":"2021","journal-title":"Brain Behav Immun"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"175628642199890","DOI":"10.1177\/1756286421998906","article-title":"Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression","volume":"14","author":"Banks","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"837376","DOI":"10.3389\/fimmu.2022.837376","article-title":"Cerebrospinal fluid Total tau protein correlates with longitudinal, progressing cognitive dysfunction in anti-neural autoantibody-associated dementia and Alzheimer's dementia: a case-control study","volume":"13","author":"Hansen","year":"2022","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.7150\/thno.72126","article-title":"Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases","volume":"12","author":"Kocurova","year":"2022","journal-title":"Theranostics"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"778684","DOI":"10.3389\/fpsyt.2021.778684","article-title":"Impaired verbal memory recall in patients with axonal degeneration and serum Glycine-receptor autoantibodies-case series","volume":"12","author":"Hansen","year":"2021","journal-title":"Front Psychol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/brainsci11010089","article-title":"KCNA2 autoimmunity in progressive cognitive impairment: case series and literature review","volume":"11","author":"Timaus","year":"2021","journal-title":"Brain Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"6723","DOI":"10.1038\/s41598-017-06117-y","article-title":"Anti-AMPA GluA3 antibodies in frontotemporal dementia: a new molecular target","volume":"7","author":"Borroni","year":"2017","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41582-019-0231-z","article-title":"Neuroinflammation in frontotemporal dementia","volume":"15","author":"Bright","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit GluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2019.10.015","article-title":"Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure","volume":"86","author":"Palese","year":"2020","journal-title":"Neurobiol Aging"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","article-title":"Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders","volume":"24","author":"Brandebura","year":"2023","journal-title":"Nat Rev Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein Astrocytopathy: a novel Meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1212\/WNL.0000000000013087","article-title":"Glial fibrillary acidic protein autoimmunity: a French cohort study","volume":"98","author":"Gravier-Dumonceau","year":"2022","journal-title":"Neurology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000505730","article-title":"Overlapping clinical syndromes in patients with glial fibrillary acidic protein IgG","volume":"27","author":"Lin","year":"2020","journal-title":"Neuroimmunomodulation"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/acn3.51513","article-title":"Rapidly progressive dementia: extending the spectrum of GFAP-astrocytopathies?","volume":"9","author":"Friedrich","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"760021","DOI":"10.3389\/fimmu.2021.760021","article-title":"Case report: semantic variant of primary progressive aphasia associated with anti-glial fibrillary acid protein autoantibodies","volume":"12","author":"Hansen","year":"2021","journal-title":"Front Immunol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1161\/01.STR.23.8.1078","article-title":"Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects","volume":"23","author":"Lopez","year":"1992","journal-title":"Stroke"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0165-1781(95)02703-3","article-title":"Autoantibody reactivity in serum of patients with Alzheimer's disease and other age-related dementias","volume":"59","author":"Schott","year":"1996","journal-title":"Psychiatry Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00406-017-0768-z","article-title":"Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias","volume":"268","author":"Busse","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.autrev.2010.07.008","article-title":"Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression","volume":"9","author":"Colasanti","year":"2010","journal-title":"Autoimmun Rev"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3233\/JAD-170882","article-title":"Antibodies to multiple receptors are associated with neuropsychiatric symptoms and mortality in Alzheimer's disease: a longitudinal study","volume":"64","author":"Giil","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1021\/acs.jproteome.9b00258","article-title":"Identification of Alzheimer's disease autoantibodies and their target biomarkers by phage microarrays","volume":"18","author":"San Segundo-Acosta","year":"2019","journal-title":"J Proteome Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e0192778","DOI":"10.1371\/journal.pone.0192778","article-title":"Functional autoantibodies in patients with different forms of dementia","volume":"13","author":"Wallukat","year":"2018","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1111\/ene.14290","article-title":"Identification of novel candidate autoantibodies in Alzheimer's disease","volume":"27","author":"Wang","year":"2020","journal-title":"Eur J Neurol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.autrev.2017.10.011","article-title":"Rheumatic diseases and autoimmune vascular dementia","volume":"16","author":"Atzeni","year":"2017","journal-title":"Autoimmun Rev"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fimmu.2018.00067","article-title":"Emerging role of immunity in cerebral small vessel disease","volume":"9","author":"Fu","year":"2018","journal-title":"Front Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/1744-9987.12415","article-title":"Immunoadsorption of agonistic autoantibodies against alpha1-adrenergic receptors in patients with mild to moderate dementia","volume":"20","author":"Hempel","year":"2016","journal-title":"Ther Apher Dial"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1077204","DOI":"10.3389\/fncel.2023.1077204","article-title":"Brain blood vessel autoantibodies in patients with NMDA and GABA(a) receptor encephalitis: identification of unconventional myosin-X as target antigen","volume":"17","author":"Li","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2018.10.006","article-title":"Antinuclear antibodies in frontotemporal dementia: the tip's of autoimmunity iceberg?","volume":"325","author":"Cavazzana","year":"2018","journal-title":"J Neuroimmunol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e2022076","DOI":"10.4084\/MJHID.2022.076","article-title":"Detection of antinuclear antibodies targeting intracellular signal transduction, metabolism, apoptotic processes and cell death in critical COVID-19 patients","volume":"14","author":"Nasarallah","year":"2022","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41419-019-2106-z","article-title":"Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function","volume":"10","author":"Rocchi","year":"2019","journal-title":"Cell Death Dis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2023.01.006","article-title":"Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome","volume":"109","author":"Franke","year":"2023","journal-title":"Brain Behav Immun"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbi.2020.12.022","article-title":"High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms","volume":"93","author":"Franke","year":"2021","journal-title":"Brain Behav Immun"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1412813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:20:46Z","timestamp":1720585246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1412813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":59,"alternative-id":["10.3389\/fneur.2024.1412813"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1412813","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"article-number":"1412813"}}